Expression of c-MET in Estrogen Receptor Positive and HER2 Negative Resected Breast Cancer Correlated with a Poor Prognosis
Introduction: The mesenchymal-epithelial transition factor (c-MET) receptor is overexpressed in about 14–54% of invasive breast cancers, but its prognostic value in clinical practice is still unclear. Methods: In order to investigate the relationship between c-MET expression levels and prognosis, we...
Main Authors: | Francesco Iovino, Anna Diana, Francesca Carlino, Franca Ferraraccio, Giuliano Antoniol, Francesca Fisone, Alessandra Perrone, Federica Zito Marino, Iacopo Panarese, Madhura S. Tathode, Michele Caraglia, Gianluca Gatta, Roberto Ruggiero, Simona Parisi, Ferdinando De Vita, Fortunato Ciardiello, Ludovico Docimo, Michele Orditura |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-11-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/11/23/6987 |
Similar Items
-
Enhanced Wild-Type MET Receptor Levels in Mouse Hepatocytes Attenuates Insulin-Mediated Signaling
by: Patricia Rada, et al.
Published: (2022-02-01) -
Hypoxia activated HGF expression in pancreatic stellate cells confers resistance of pancreatic cancer cells to EGFR inhibitionResearch in context
by: Xiuhui Shi, et al.
Published: (2022-12-01) -
Blocking c‐Met signaling enhances bone morphogenetic protein‐2‐induced osteoblast differentiation
by: Seiji Shibasaki, et al.
Published: (2015-01-01) -
The relationship between clinical parameters and hepatocyte growth factor/c-Met levels in the sperm of infertile males
by: Basak Ozge Kayan, et al.
Published: (2022-08-01) -
Rilotumumab Resistance Acquired by Intracrine Hepatocyte Growth Factor Signaling
by: Fabiola Cecchi, et al.
Published: (2023-01-01)